The preclinical discovery and development of the combination of ivacaftor + tezacaftor used to treat cystic fibrosis-Reference-Cited by-同舟云学术

The preclinical discovery and development of the combination of ivacaftor + tezacaftor used to treat cystic fibrosis

Published:2020-04-15 Issue:8 Volume:15 Page:873-891
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Guerra Lorenzo¹,Favia Maria¹,Di Gioia Sante²,Laselva Onofrio³⁴^ORCID,Bisogno Arianna⁵,Casavola Valeria¹,Colombo Carla⁵,Conese Massimo²

Affiliation:

1. Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy

2. Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy

3. Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada

4. Department of Physiology, University of Toronto, Toronto, Ontario, Canada

5. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Centro Regionale di Riferimento per la Fibrosi Cistica, Università degli Studi di Milano, Milan, Italy

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2020.1750592

Reference150 articles.

1. Cystic Fibrosis and Its Management Through Established and Emerging Therapies

2. Cystic fibrosis genetics: from molecular understanding to clinical application

3. Cystic fibrosis

4. Innate immunity in cystic fibrosis lung disease

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023);Journal of Medicinal Chemistry;2024-07-12

2. Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): Structure, classification, and mechanisms;European Journal of Medicinal Chemistry;2024-02

3. Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5;Journal of Medicinal Chemistry;2023-07-13

4. Air-Liquid interface cultures to model drug delivery through the mucociliary epithelial barrier;Advanced Drug Delivery Reviews;2023-07

5. Divergent Approaches Toward Drug Discovery and Development;The Quintessence of Basic and Clinical Research and Scientific Publishing;2023